Dr. Lewis Joseph Overton, MD

Dr. Overton practices at Wakemed Specialists Group in Raleigh, North Carolina.

Dr. Overton's NPI, 1710323704, was assigned on May 16, 2013. Dr. Overton graduated from Medical University of South Carolina (MUSC) in 2013. Dr. Overton holds North Carolina license 2019-00891.

Dr. Overton's primary practice is Wakemed Specialists Group, at 2920 Highwoods Blvd, Raleigh, NC 27604 in Wake County. The practice phone is (919) 350-7856.

Dr. Overton's primary practice is Wakemed Specialists Group in Raleigh, North Carolina. Dr. Overton is also affiliated with WakeMed Raleigh Campus. The medical group on file is WakeMed Physician Practices. Dmand AI also links Dr. Overton to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Overton practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Overton's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Overton is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Overton is licensed in North Carolina.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery, hearing loss and impairment, swimmer's ear and thyroid surgery among the conditions Dr. Overton treats.

CMS data shows 506 Medicare services from Dr. Overton across 9 procedure codes in 2024, for 214 Medicare patients. Medicare paid $32,319 for them. Every service was in an office.

CMS counts 214 Medicare patients who saw Dr. Overton in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Overton's median patient age at 47, with 50% women.

In 2024, Dr. Overton wrote 232 Medicare Part D claims for 92 patients. 93% of them were for generic drugs. CMS names the drug for 91 of them, across 6 drugs with 11 or more claims each, at $1,239 in total drug cost. In 2023, CMS named 134 claims across 8 drugs.

Dr. Overton accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Overton, published from 2012 to 2020. 2013 was the busiest year, with 3. The most frequent topics are Laryngeal Diseases, Laryngoplasty and Polytetrafluoroethylene. Dr. Overton has published most often in Laryngoscope. Dr. Overton's most frequent co-authors are Robert Arthur Buckmire, MD, Zainab Farzal, MD and Rounak Babula Rawal, MD.

CMS Open Payments shows 17 general payments to Dr. Overton from 10 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Stryker Corporation paid the most, $164.

Dr. Overton graduated from Medical University of South Carolina (MUSC) in 2013. Dr. Overton is a member of NHS and North American Skull Base Society.

Dr. Overton is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.